0798-0000-18-224-H01-P (for Pharmacists); 0798-0000-18-224-H01-T (for Technicians) August (1.25 contact hours)

Carbapenem Resistant Enterobacteriaceae (CRE) infections are becoming more common and are a tremendous burden to patients and the healthcare system. The social, economic and personal costs related to them are overwhelming. Many researchers have demonstrated various interventions that decrease infection rates. A multi-faceted approach that includes staff education, minimizing patient risk factors and easy to understand institutional guidelines are needed to prevent these infections. This is an active area of research with advancements to patient care published frequently. In the last lesson (Part 1), we reviewed the definition of CRE infections, the risk factors associated with acquiring CRE infections, identification of CRE infections, and general treatment. In this lesson (Part 2), we review specific therapies, and we relate how CRE infections can be prevented.